SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gene Voss who wrote (2779)1/18/1998 1:00:00 AM
From: Afaq Sarwar  Read Replies (1) of 3906
 
Gene Voss,

The following is from the US Patent Office web site:

"ALLOWANCE AND ISSUE OF PATENT

If, on examination of the application, or at a later stage during the reconsideration of the application, the patent application is found to be allowable, a notice of allowance will be sent to the applicant, or to applicant's attorney or agent of record, if any, and a fee for issuing the patent is due within three months from the date of the notice. If timely payment of the issue fee is not made, the application will be
regarded as abandoned. See current fee schedule.

A provision is made in the statute whereby the Commissioner may accept the fee late, when the delay is shown to be unavoidable. When the issue fee is paid, the patent issues as soon as possible after the date of payment, dependent upon the volume of printing on hand. The patent grant then is delivered or mailed on the day of its grant, or as soon thereafter as possible, to the inventor's attorney or agent if there is one of record, otherwise directly to the inventor. On the date of the grant, the patent file becomes open to the public. Printed copies of the specification and drawing are available on the same date."

Also the following news was released by the company:

"RENO, Nev., Aug. 19 /PRNewswire/ -- Harvard Scientific Corp. (OTC BULLETIN BOARD: HVSF) announced today that on Thursday, August 14, 1997, the U.S. Patent and Trademark office notified the company's patent counsel, that it has allowed all claims of its patent application entitled PGE-1 Lyophilized Liposomes for use in the treatment of ERECTILE DYSFUNCTION for issuance."

Further I was told by the company that the required fee has been paid, and they are expecting to receive the grant of patent as soon as it is printed.

Hope that hepls.

Afaq Sarwar
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext